For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a million people each year in the U.S. Now, a breakthrough may be within reach.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

In today’s Health Alert, tick season is back and so is the threat of Lyme disease. But, there is good news on the medical ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

One vaccine to note is Pfizer and Valneva’s Lyme borreliosis vaccine candidate, VLA15. Annually, Lyme disease is responsible for over 475,000 infections in the US and nearly 130,000 infections in ...

Lyme disease is the fastest-grown vector-borne illness in the United States, with over 476,000 new cases annually, according to the Global Lyme Alliance, a national not-for-profit organization whose ...

This cat vaccine market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market ...

While the knowledge of ticks being vectors for Lyme disease is ubiquitous, there’s a lesser-known threat these insects carry that's concerning health experts: the Powassan virus. As the tick season ...

Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development ...